[Pharmacodynamic aspects of reproterol].
D000420:Albuterol / Q000494:pharmacology; D000818:Animals; D001285:Atropine / Q000494:pharmacology; D001980:Bronchi / Q000187:drug effects* / Q000201:enzymology; D001986:Bronchial Spasm / Q000139:chemically induced; D001993:Bronchodilator Agents / Q000494:pharmacology*; D002976:Clenbuterol / Q000494:pharmacology; D004338:Drug Combinations; D004347:Drug Interactions; D006168:Guinea Pigs; D006632:Histamine / Q000009:adverse effects; D066298:In Vitro Techniques; D007545:Isoproterenol / Q000494:pharmacology; D008660:Metabolism / Q000187:drug effects; D009921:Metaproterenol / Q000031:analogs & derivatives* / Q000494:pharmacology; D010208:Papaverine / Q000494:pharmacology; D011898:Ranidae; D051381:Rats; D013806:Theophylline / Q000031:analogs & derivatives* / Q000494:pharmacology; D014132:Trachea / Q000187:drug effects*
D001993:Bronchodilator Agents; D004338:Drug Combinations; C014792:reproterol; D009921:Metaproterenol; D001285:Atropine; D006632:Histamine; D013806:Theophylline; D010208:Papaverine; D007545:Isoproterenol; D000420:Albuterol; D002976:Clenbuterol
Aspetti farmacodinamici del reproterolo.